Viewing Study NCT00683306


Ignite Creation Date: 2025-12-26 @ 1:16 PM
Ignite Modification Date: 2025-12-26 @ 1:16 PM
Study NCT ID: NCT00683306
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2018-09-13
First Post: 2008-05-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Open Label Extension Study With Gefitinib (IRESSAâ„¢) for Completing Trial Patients Who May Benefit From Further Treatment
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module